Overexpression of fatty acid synthase in ulcerative colitis

American Journal of Clinical Pathology

Volumn 126, Issue 1, 2006, Pages 113-118

  Consolazio, Adriana ^a,b   Alò, Piero Luigi ^a   Rivera, Margherita ^a   Iacopini, Federico ^a   Paoluzi, Omero Alessandro ^a   Crispino, Pietro ^a   Pica, Roberta ^a   Paoluzi, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Fatty acid synthase; Inflammation; Ulcerative colitis

Indexed keywords

FATTY ACID SYNTHASE; LONG CHAIN FATTY ACID;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DYSPLASIA; ENTERITIS; ENZYME ANALYSIS; ENZYME MECHANISM; FATTY ACID SYNTHESIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLON; FATTY ACID SYNTHETASE COMPLEX; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; MALE; MIDDLE AGED;

EID: 33745771550     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/PUBVQNDNVQKJVC8M     Document Type: Article

References (36)

1. Wakil SJ. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry. 1989;28:4523-4530.
2. Swinnen JV, Heemers H, Deboel L, et al. Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene. 2000;19:5173-5181.
3. Kusakabe T, Maeda M, Hoshi N, et al. Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. J Histochem Cytochem. 2000;48:613-622.
4. Sul HS, Wang D. Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3 phosphate acyltransferase gene transcription. Annu Rev Nutr. 1998;18:331-351.
5. Chalbos D, Chambon M, Aihaud G, et al. Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. J Biol Chem. 1987;262:9923-9926.
6. Kuhajda FP, Piantadosi S, Pasternack GR. Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease. N Engl J Med. 1989;321:636-641.
7. Alò PL, Visca P, Marci A, et al. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer. 1996;77:474-482.
8. Epstein JI, Carmichael M, Partin AW. OA-519 (fatty acid synthase) as an independent predictor of pathological stage in adenocarcinoma of the prostate. Urology. 1995;45:81-86.
9. Rashid A, Pizer ES, Moga M, et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol. 1997;150:201-208.
10. Visca P Alò PL, Del Nonno F, et al. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Clin Cancer Res. 1999;5:4111-4118.
11. Piyathilake CJ, Frost AR, Manne U, et al. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol. 2000;31:1068-1073.
12. Visca P, Sebastiani V, Botti C, et al. Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma. Anticancer Res. 2004;24:4169-4173.
13. Kusakabe T, Nashimoto A, Honna K, et al. Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology. 2002;40:71-79.
14. Yang YA, Han WF, Morin PJ, et al. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp Cell Res. 2002;279:80-90.
15. Tsianos EV. Risk of cancer in inflammatory bowel disease (IBD). Eur J Intern Med. 2000;11:75-78.
16. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91:854-862.
17. Truelove SC, Horler AR, Richards WC. Serial biopsy in ulcerative colitis. Br Med J. 1955;4956:1590-1593.
18. Pizer ES, Thupari J, Fang Han W, et al. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res. 2000;60:213-218.
19. Sebastiani V, Visca P, Botti C, et al. Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma. Gynecol Oncol 2004;92:101-105.
20. Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol. 1996;27:917-921.
21. Gansler TS, Hardman W, Hunt DA, et al. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 1997;28:686-692.
22. Kuhajda FP, Jenner K, Wood FD, et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A. 1994;91:6379-6383.
23. Yukawa M, Iizuka M, Horie Y, et al. Systemic and local evidence of increased Fas-mediated apoptosis in ulcerative colitis. Int J Colorectal Dis. 2002;17:70-76.
24. Jung HC, Eckmann L, Yang SK, et al. A distinct array of pro inflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest. 1995;95:55-65.
25. Feingold KR, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest. 1987;80:184-190.
26. Hsu DKW, Donohue PJ, Alberts GF, et al. Fibroblast growth factor-1 induces phosphofructokinase, fatty acid synthase and Ca-ATPase mRN A expression in NIH 3T3 cells. Biochem Biophys Res Commun. 1993;197:1483-1491.
27. Pizer ES, Lax SF, Kuhajda FP, et al. Fatty acid synthase expression in endometrial carcinoma. Cancer. 1998;1:528-537.
28. McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system: from concept to molecular analysis. Eur J Biochem. 1997;244:1-14.
29. Zhou W, Simpson PJ, McFadden JM, et al. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res. 2003;63:7330-7337.
30. Landreet LE, Hanlon AL, Strong DW, et al. C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism. J Biol Chem. 2004;279:3817-3827.
31. Semenkovich CF, Coleman T, Goforth R. Physiologic concentrations of glucose regulate fatty acid synthase activity in HepG2 cells by mediating fatty acid synthase mRNA. J Biol Chem. 1993;268:6961-6970.
32. Paumen MB, Ishida Y, Muramatsu M, et al. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J Biol Chem. 1997;272:3324-3329.
33. Sharma K, Shi Y. The yins and yangs of ceramide. Cell Res. 1999;9:1-10.
34. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science. 1996;274:1855-1859.
35. Wood LC, Jackson SM, Elies PM, et al. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 1992;90:482-487.
36. Ottey KA, Wood LC, Grunfeld C, et al. Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice. J Invest Dermatol. 1995;104:401-404.